Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Bryant, Christopher S ^b   Kumar, Sanjeev ^b   Chamala, Sreedhar ^a,b   Shah, Jay ^a   Pal, Jagannath ^a   Haider, Mahdi ^b   Seward, Shelly ^b   Qazi, Aamer M ^a,b   Morris, Robert ^b   Semaan, Assaad ^b   Shammas, Masood A ^a   Steffes, Christopher ^a,b   Potti, Ravindra B ^a   Prasad, Madhu ^a   Weaver, Donald W ^a   Batchu, Ramesh B ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CYCLIN DEPENDENT KINASE; CYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROCASPASE 9; PROTEIN BAK; PROTEIN BCL 2; PROTEIN P107; PROTEIN P130; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; SULFORAPHANE; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F3; TUMOR SUPPRESSOR PROTEIN; CELL CYCLE PROTEIN; DNA; SULFORAFAN; THIOCYANIC ACID DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IC 50; MIGRATION INHIBITION; OVARY CANCER; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CANCER INVASION; CELL CYCLE; CELL CYCLE S PHASE; CELL MOTION; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE; WOUND HEALING;

BRASSICA OLERACEA VAR. GEMMIFERA; BRASSICA OLERACEA VAR. ITALICA;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA, NEOPLASM; E2F1 TRANSCRIPTION FACTOR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PACLITAXEL; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; S PHASE; THIOCYANATES; WOUND HEALING;

EID: 77950552489     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-47     Document Type: Article

References (27)

1. Trimbos JB, Timmers P. Chemotherapy for early ovarian cancer. Current Opinion in Obstetrics & Gynecology 2004, 16:43-48.
2. Vergote I, Trimbos BJ. Treatment of patients with early epithelial ovarian cancer. Current Opinion in Oncology 2003, 15:452-455. 10.1097/00001622-200311000-00008, 14624228.
3. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer [see comment]. New England Journal of Medicine 1996, 334:1-6. 10.1056/NEJM199601043340101, 7494563.
4. Ozols RF. Challenges for chemotherapy in ovarian cancer. Annals of Oncology 2006, 17(Suppl 5):v181-187. 10.1093/annonc/mdj978, 16807453.
5. Keum YS, Jeong WS, Kong AN, Keum Y-S, Jeong W-S, Kong ANT. Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutation Research 2004, 555:191-202.
6. Talalay P, Fahey JW. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. Journal of Nutrition 2001, 131:3027S-3033S.
7. Myzak MC, Dashwood RH, Myzak MC, Dashwood RH. Chemoprotection by sulforaphane: keep one eye beyond Keap1. Cancer Letters 2006, 233:208-218. 10.1016/j.canlet.2005.02.033, 2276573, 16520150.
8. Park EJ, Pezzuto JM, Park EJ, Pezzuto JM. Botanicals in cancer chemoprevention. Cancer & Metastasis Reviews 2002, 21:231-255.
9. Chaudhuri D, Orsulic S, Ashok BT. Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells. Molecular Cancer Therapeutics 2007, 6:334-345. 10.1158/1535-7163.MCT-06-0404, 2584019, 17237292.
10. Bodo J, Hunakova L, Kvasnicka P, Jakubikova J, Duraj J, Kasparkova J, Sedlak J. Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations. British Journal of Cancer 2006, 95:1348-1353. 10.1038/sj.bjc.6603434, 2360594, 17060935.
11. Satyan KS, Swamy N, Dizon DS, Singh R, Granai CO, Brard L, Swamy N, Dizon DS, Singh R, Granai CO, Brard L. Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. Gynecologic Oncology 2006, 103:261-270. 10.1016/j.ygyno.2006.03.002, 16624391.
12. Kalkunte S, Swamy N, Dizon DS, Brard L, Kalkunte S, Swamy N, Dizon DS, Brard L. Benzyl isothiocyanate (BITC) induces apoptosis in ovarian cancer cells in vitro [see comment]. Journal of Experimental Therapeutics & Oncology 2006, 5:287-300.
13. Duraj J, Hunakova L, Bodo J, Jakubikova J, Chovancova J, Sedlak J. Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells. Neoplasma 2009, 56:208-214. 10.4149/neo_2009_03_208, 19309223.
14. Singh RK, Lange TS, Kim KK, Singh AP, Vorsa N, Brard L. Isothiocyanate NB7 M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells. British Journal of Cancer 2008, 99:1823-1831. 10.1038/sj.bjc.6604778, 2600706, 19002174.
15. DiCiommo D, Gallie BL, Bremner R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Seminars in Cancer Biology 2000, 10:255-269. 10.1006/scbi.2000.0326, 10966849.
16. La Thangue NB. DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control. Current Opinion in Cell Biology 1994, 6:443-450. 10.1016/0955-0674(94)90038-8, 7917337.
17. Kumar S, Bryant C, Chamala S, Qazi A, Seward S, Pal J, Steffes C, Weaver D, Morris R, Malone J. Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells. Molecular Cancer 2009, 8:26. 10.1186/1476-4598-8-26, 2691728, 19386116.
18. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. Journal of Biological Chemistry 1990, 265:4923-4928.
19. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods 1995, 184:39-51. 10.1016/0022-1759(95)00072-I, 7622868.
20. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Research 2000, 60:3689-3695.
21. Vidal A, Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene 2000, 247:1-15. 10.1016/S0378-1119(00)00092-5, 10773440.
22. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001[erratum appears in CA Cancer J Clin 2001 Mar-Apr;51(2):144]. CA: a Cancer Journal for Clinicians 2001, 51:15-36. 10.3322/canjclin.51.1.15, 11577478.
23. Choi S, Singh SV, Choi S, Singh SV. Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Cancer Research 2005, 65:2035-2043. 10.1158/0008-5472.CAN-04-3616, 15753404.
24. Suh DS, Yoon MS, Choi KU, Kim JY. Significance of E2F-1 overexpression in epithelial ovarian cancer. International Journal of Gynecological Cancer 2008, 18:492-498. 10.1111/j.1525-1438.2007.01044.x, 17692085.
25. Reimer D, Sadr S, Wiedemair A, Goebel G, Concin N, Hofstetter G, Marth C, Zeimet AG, Reimer D, Sadr S, Wiedemair A, Goebel G, Concin N, Hofstetter G, Marth C, Zeimet AG. Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer. Annals of the New York Academy of Sciences 2006, 1091:270-281. 10.1196/annals.1378.073, 17341621.
26. Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E, Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 2006, 27:811-819. 10.1093/carcin/bgi265, 2276576, 16280330.
27. Steeg PS, Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nature Medicine 2006, 12:895-904. 10.1038/nm1469, 16892035.